Latest filing published 29 Sept 2026 for Aterian, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David E. Lazar: trading record in brief
David E. Lazar has filed trades across 9 companies (mainly through SEC (Form 4)), most often in Titan Pharmaceuticals Inc, Bio Green Med Solution, Inc. and Quantum Cyber N.V. Over a trading history stretching from 6 July 2022 to 24 September 2026, the count stands at 29 filings.
In open-market terms, that means 6 purchases worth €2.0M on one side and 8 sales worth €13.7M on the other. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 2 option exercises.
Half of the purchases are above €162k and half below. None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 29 September 2026: a transaction, in Aterian, Inc. The last insider purchase was made public on 31 December 2024, 679 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David E. Lazar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,300,530 shares0Common StockSEC:0001829126-26-010590:0
- 875,000 shares@ US$2.0014.50% mcap100.0% of flowCommon StockSEC:0001829126-26-010034:0
- 9,000,000 shares@ €7.8048Ordinary SharesSEC:0001829126-26-008488:0
- 9,000,000 shares@ €7.8048Ordinary SharesSEC:0001829126-26-008488:1
- 9,000,000 shares@ €7.8048Ordinary SharesSEC:0001829126-26-008488:2
- 28,057,500 shares@ €195.12Ordinary SharesSEC:0001829126-26-008488:3
- 5,740,000 shares@ US$0.1428100.0% of flowCommon StockSEC:0001829126-26-003119:0
- 6,388,000 sharesCommon StockSEC:0000921895-26-000165:0
- 6,750 shares@ US$12.36100.0% of flowCommon StockSEC:0000921895-25-002082:0
- 100,000 shares0Common StockSEC:0001829126-25-002445:0
- 1,200,000 sharesCommon StockSEC:0000921895-25-000728:0
- 2,650,000 sharesCommon StockSEC:0000921895-25-000651:0
- 1,456,980 shares@ US$0.0343100.0% of flowCommon StockSEC:0000921895-24-003050:0Canonical exit: 26 Mar 2025 (T+90)
- 821,818 sharesCommon StockSEC:0000921895-24-002812:0
- 100,000 sharesCommon StockSEC:0000921895-24-000829:0
- 25,000 sharesCommon StockSEC:0000921895-24-000127:0
- 100,000 shares0Common StockSEC:0000921895-23-001766:0
- 3,388,902 shares@ US$1.2344.6% of flowCommon Stock, par value $0.001SEC:0000921895-23-001593:0
- 3,388,902 shares@ US$1.2380.5% of flowCommon Stock, par value $0.001SEC:0000921895-23-001569:0
- 37,500 shares@ US$0.96590.7% of flowCommon Stock, par value $0.001SEC:0000921895-23-000200:0Canonical exit: 24 Apr 2023 (T+90)
- 1,165,975 shares@ US$0.773518.8% of flowCommon Stock, par value $0.001SEC:0001829126-22-014209:0Canonical exit: 4 Oct 2022 (T+90)
21 of 21 declarations
